Synapse - Dmitriy Zamarin

Results (27)

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: A case series

Journal Article

Sia, T. Y.; Wan, V.; Finlan, M.; Zhou, Q. C.; Iasonos, A.; Zivanovic, O.; Sonoda, Y.; Chi, D. S.; Long Roche, K.; Jewell, E.; more...
International Journal of Gynecological Cancer (2024)

Fulltext@MSK | Save

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Journal Article

Kahn, R. M.; Selenica, P.; Boerner, T.; Roche, K. L.; Xiao, Y.; Sia, T. Y.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
Gynecologic Oncology (2024)

Fulltext@MSK | Save

Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets

Journal Article

Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival

Meeting Abstract

Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Journal Article

Rios-Doria, E.; Momeni-Boroujeni, A.; Friedman, C. F.; Selenica, P.; Zhou, Q.; Wu, M.; Marra, A.; Leitao, M. M. Jr; Iasonos, A.; Alektiar, K. M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype

Journal Article

Dessources, K.; Ferrando, L.; Zhou, Q. C.; Iasonos, A.; Abu-Rustum, N. R.; Reis-Filho, J. S.; Riaz, N.; Zamarin, D.; Weigelt, B.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer

Journal Article

Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Journal Article

Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)

Meeting Abstract

Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)

Meeting Abstract

Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save